The conformation and orientation of a 27-residue CCR5 peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide

Journal of Molecular Biology

Volumn 410, Issue 5, 2011, Pages 778-797

  Schnur, Einat ^a   Noah, Eran ^a   Ayzenshtat, Inbal ^a   Sargsyan, Hasmik ^b   Inui, Tatsuya ^b   Ding, Fa Xiang ^b   Arshava, Boris ^b   Sagi, Yael ^a   Kessler, Naama ^a   Levy, Rina ^a   Scherf, Tali ^a   Naider, Fred ^b   Anglister, Jacob ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

chemokine; interactions; NMR; protein structure; sulfotyrosine

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GLYCOPROTEIN GP 120;

ARTICLE; BINDING AFFINITY; DEGLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEAR MAGNETIC RESONANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; SULFATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79960343575     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.04.023     Document Type: Article

References (72)

1. Freed E.O.; and Martin M.A. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection J. Biol. Chem. 270 1995 23883 23886
2. Trkola A.; Dragic T.; Arthos J.; Binley J.M.; Olson W.C.; and Allaway G.P. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 Nature 384 1996 184 187 (Pubitemid 26386476)
3. Wu L.; Gerard N.P.; Wyatt R.; Choe H.; Parolin C.; and Ruffing N. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 Nature 384 1996 179 183 (Pubitemid 26386475)
4. Feng Y.; Broder C.C.; Kennedy P.E.; and Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor Science 272 1996 872 877 (Pubitemid 26154590)
5. Chan D.C.; and Kim P.S. HIV entry and its inhibition Cell 93 1998 681 684 (Pubitemid 28257575)
6. Rizzuto C.D.; Wyatt R.; Hernandez-Ramos N.; Sun Y.; Kwong P.D.; Hendrickson W.A.; and Sodroski J. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding Science 280 1998 1949 1953 (Pubitemid 28299405)
7. + channel C terminus: evidence for a role of helical structures in modulation of channel inactivation J. Biol. Chem. 277 2002 9233 9241 (Pubitemid 34953004)
8. Wu X.; Sambor A.; Nason M.C.; Yang Z.Y.; Wu L.; and Zolla-Pazner S. Soluble CD4 broadens neutralization of V3-directed monoclonal antibodies and guinea pig vaccine sera against HIV-1 subtype B and C reference viruses Virology 380 2008 285 295
9. Tugarinov V.; Zvi A.; Levy R.; Hayek Y.; Matsushita S.; and Anglister J. NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding Structure 8 2000 385 395 (Pubitemid 30202899)
10. Sharon M.; Kessler N.; Levy R.; Zolla-Pazner S.; Gorlach M.; and Anglister J. Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity Structure (London) 11 2003 225 236 (Pubitemid 36183646)
11. Rosen O.; Chill J.; Sharon M.; Kessler N.; Mester B.; Zolla-Pazner S.; and Anglister J. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization Biochemistry 44 2005 7250 7258 (Pubitemid 40656668)
12. Cormier E.G.; and Dragic T. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor J. Virol. 76 2002 8953 8957 (Pubitemid 34864089)
13. Mueller A.; and Strange P.G. The chemokine receptor, CCR5 Int. J. Biochem. Cell Biol. 36 2004 35 38 (Pubitemid 37338472)
14. Lusso P. HIV and chemokines: implications for therapy and vaccine Vaccine 20 2002 1964 1967 (Pubitemid 34450795)
15. Clapham P.R.; and McKnight A. HIV-1 receptors and cell tropism Br. Med. Bull. 58 2001 43 59 (Pubitemid 33070763)
16. Dean M.; Carrington M.; Winkler C.; Huttley G.A.; Smith M.W.; and Allikmets R. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study Science 273 1996 1856 1862
17. Liu R.; Paxton W.A.; Choe S.; Ceradini D.; Martin S.R.; and Horuk R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection Cell 86 1996 367 377 (Pubitemid 26272077)
18. Samson M.; Libert F.; Doranz B.J.; Rucker J.; Liesnard C.; and Farber C.M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene Nature 382 1996 722 725
19. Barre-Sinoussi F.; Chermann J.C.; Rey F.; Nugeyre M.T.; Chamaret S.; and Gruest J. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science 220 1983 868 871 (Pubitemid 13080157)
20. Dorr P.; Westby M.; Dobbs S.; Griffin P.; Irvine B.; and Macartney M. Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity Antimicrob. Agents Chemother. 49 2005 4721 4732 (Pubitemid 41552605)
21. Dragic T.; Trkola A.; Lin S.W.; Nagashima K.A.; Kajumo F.; and Zhao L. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry J. Virol. 72 1998 279 285 (Pubitemid 28048838)
22. Farzan M.; Choe H.; Vaca L.; Martin K.; Sun Y.; and Desjardins E. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5 J. Virol. 72 1998 1160 1164 (Pubitemid 28116898)
23. Lee B.; Sharron M.; Blanpain C.; Doranz B.J.; Vakili J.; and Setoh P. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function J. Biol. Chem. 274 1999 9617 9626
24. Samson M.; LaRosa G.; Libert F.; Paindavoine P.; Detheux M.; Vassart G.; and Parmentier M. The second extracellular loop of CCR5 is the major determinant of ligand specificity J. Biol. Chem. 272 1997 24934 24941 (Pubitemid 27415669)
25. Blanpain C.; Migeotte I.; Lee B.; Vakili J.; Doranz B.J.; and Govaerts C. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist Blood 94 1999 1899 1905 (Pubitemid 29430405)
26. Farzan M.; Vasilieva N.; Schnitzler C.E.; Chung S.; Robinson J.; and Gerard N.P. A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry J. Biol. Chem. 275 2000 33516 33521
27. Farzan M.; Mirzabekov T.; Kolchinsky P.; Wyatt R.; Cayabyab M.; and Gerard N.P. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry Cell 96 1999 667 676 (Pubitemid 29122809)
28. Cormier E.G.; Persuh M.; Thompson D.A.; Lin S.W.; Sakmar T.P.; Olson W.C.; and Dragic T. Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120 Proc. Natl Acad. Sci. USA 97 2000 5762 5767 (Pubitemid 30367472)
29. Choe H.; Martin K.A.; Farzan M.; Sodroski J.; Gerard N.P.; and Gerard C. Structural interactions between chemokine receptors, gp120 Env and CD4 Semin. Immunol. 10 1998 249 257 (Pubitemid 28347041)
30. Brower E.T.; Schon A.; Klein J.C.; and Freire E. Binding thermodynamics of the N-terminal peptide of the CCR5 coreceptor to HIV-1 envelope glycoprotein gp120 Biochemistry 48 2009 779 785
31. Wu B.; Chien E.Y.; Mol C.D.; Fenalti G.; Liu W.; and Katritch V. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists Science 330 2010 1066 1071
32. Huang C.C.; Lam S.N.; Acharya P.; Tang M.; Xiang S.H.; and Hussan S.S. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4 Science 317 2007 1930 1934 (Pubitemid 47509439)
33. Rabut G.E.; Konner J.A.; Kajumo F.; Moore J.P.; and Dragic T. Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1 J. Virol. 72 1998 3464 3468 (Pubitemid 28175601)
34. Martin L.; Stricher F.; Misse D.; Sironi F.; Pugniere M.; and Barthe P. Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes Nat. Biotechnol. 21 2003 71 76 (Pubitemid 36055830)
35. Huang C.C.; Stricher F.; Martin L.; Decker J.M.; Majeed S.; and Barthe P. Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth Structure 13 2005 755 768 (Pubitemid 40704664)
36. Howlett G.J.; Minton A.P.; and Rivas G. Analytical ultracentrifugation for the study of protein association and assembly Curr. Opin. Chem. Biol. 10 2006 430 436 (Pubitemid 44375070)
37. Myszka D.G.; Sweet R.W.; Hensley P.; Brigham-Burke M.; Kwong P.D.; and Hendrickson W.A. Energetics of the HIV gp120-CD4 binding reaction Proc. Natl Acad. Sci. USA 97 2000 9026 9031 (Pubitemid 30626667)
38. Mechulam A.; Cerutti M.; Pugniere M.; Misse D.; Gajardo J.; and Roquet F. Highly conserved beta16/beta17 beta-hairpin structure in human immunodeficiency virus type 1 YU2 gp120 is critical for CCR5 binding J. Mol. Med. 83 2005 542 552 (Pubitemid 41126070)
39. Koradi, R.; Billeter, M. & Wuthrich, K. (1996). MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graphics, 14, 51-55, 29-32. (Pubitemid 26152976)
40. Kabsch W.; and Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen bonded and geometrical features Biopolymers 22 1983 2577 2637
41. Mayer M.; and Meyer B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy Angew. Chem.; Int. Ed. 38 1999 1784 1788 (Pubitemid 29290947)
42. Mayer M.; and Meyer B. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor J. Am. Chem. Soc. 123 2001 6108 6117 (Pubitemid 32888480)
43. Samson A.O.; Chill J.H.; and Anglister J. Two-dimensional measurement of proton T1rho relaxation in unlabeled proteins: mobility changes in alpha-bungarotoxin upon binding of an acetylcholine receptor peptide Biochemistry 44 2005 10926 10934 (Pubitemid 41153653)
44. 1H nuclear magnetic resonance to study high-affinity antibody-peptide interactions Methods Enzymol. 203 1991 202 228
45. Zvi A.; Kustanovich I.; Feigelson D.; Levy R.; Eisenstein M.; and Matsushita S. NMR mapping of the antigenic determinant recognized by an anti-gp120, human immunodeficiency virus neutralizing antibody Eur. J. Biochem. 229 1995 178 187
46. de Vries S.J.; van Dijk M.; and Bonvin A.M. The HADDOCK web server for data-driven biomolecular docking Nat. Protoc. 5 2010 883 897
47. Cormier E.G.; Tran D.N.; Yukhayeva L.; Olson W.C.; and Dragic T. Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes J. Virol. 75 2001 5541 5549 (Pubitemid 32488147)
48. Blanpain C.; Doranz B.J.; Vakili J.; Rucker J.; Govaerts C.; and Baik S.S. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein J. Biol. Chem. 274 1999 34719 34727 (Pubitemid 129509512)
49. Lam S.N.; Acharya P.; Wyatt R.; Kwong P.D.; and Bewley C.A. Tyrosine-sulfate isosteres of CCR5 N-terminus as tools for studying HIV-1 entry Bioorg. Med. Chem. 16 2008 10113 10120
50. Duma L.; Haussinger D.; Rogowski M.; Lusso P.; and Grzesiek S. Recognition of RANTES by extracellular parts of the CCR5 receptor J. Mol. Biol. 365 2007 1063 1075 (Pubitemid 46014180)
51. Farzan M.; Babcock G.J.; Vasilieva N.; Wright P.L.; Kiprilov E.; Mirzabekov T.; and Choe H. The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1 alpha association and HIV-1 entry J. Biol. Chem. 277 2002 29484 29489 (Pubitemid 41079234)
52. Veldkamp C.T.; Seibert C.; Peterson F.C.; Sakmar T.P.; and Volkman B.F. Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) J. Mol. Biol. 359 2006 1400 1409 (Pubitemid 43903502)
53. De Jong J.J.; De Ronde A.; Keulen W.; Tersmette M.; and Goudsmit J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution J. Virol. 66 1992 6777 6780
54. Rosen O.; Samson A.O.; and Anglister J. Correlated mutations at gp120 positions 322 and 440: implications for gp120 structure Proteins 71 2008 1066 1070 (Pubitemid 351564034)
55. Yagami T.; Shiwa S.; Futaki S.; and Kitagawa K. Evaluation of the final deprotection system for the solid-phase synthesis of Tyr(SO3H)-containing peptides with 9-fluorenylmethyloxycarbonyl (Fmoc)-strategy and its application to the synthesis of cholecystokinin (CCK)-12 Chem. Pharm. Bull. (Tokyo) 41 1993 376 380 (Pubitemid 23128206)
56. Koch M.; Pancera M.; Kwong P.D.; Kolchinsky P.; Grundner C.; and Wang L. Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition Virology 313 2003 387 400 (Pubitemid 37045357)
57. Reeves P.J.; Callewaert N.; Contreras R.; and Khorana H.G. Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N- acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line Proc. Natl Acad. Sci. USA 99 2002 13419 13424 (Pubitemid 35215396)
58. Bravman T.; Bronner V.; Lavie K.; Notcovich A.; Papalia G.A.; and Myszka D.G. Exploring "one-shot" kinetics and small molecule analysis using the ProteOn XPR36 array biosensor Anal. Biochem. 358 2006 281 288 (Pubitemid 44573078)
59. Biron Z.; Khare S.; Quadt S.R.; Hayek Y.; Naider F.; and Anglister J. The 2F5 epitope is helical in the HIV-1 entry inhibitor T-20 Biochemistry 44 2005 13602 13611 (Pubitemid 41443688)
60. Chun P.W.; and Kim S.J. Determination of equilibrium constants of associating protein systems. Graphical analysis for discrete and indefinite association Biochemistry 9 1970 1957 1961
61. Piotto M.; Saudek V.; and Sklenar V. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions J. Biomol. NMR 2 1992 661 665
62. 15N HSQC experiments optimized to retain full sensitivity J. Magn. Reson.; Ser. A 102 1993 241 245
63. Hwang T.L.; and Shaka A.J. Water suppresion that works. Excitation sculpting using arbitrary waveforms and pulsed field gradients J. Magn. Reson.; Ser. A 112 1995 275 279
64. Scherf T.; and Anglister J. A T1 rho-filtered two-dimensional transferred NOE spectrum for studying antibody interactions with peptide antigens Biophys. J. 64 1993 754 761 (Pubitemid 23130342)
65. Wuthrich K. NMR of Proteins and Nucleic Acids 1986 Wiley New York, NY
66. Delaglio F.; Grzesiek S.; Vuister G.W.; Zhu G.; Pfeifer J.; and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes J. Biomol. NMR 6 1995 277 293
67. Johnson B.A.; and Blevins R.A. NMRView: a computer program for the visualization and analysis of NMR data J. Biomol. NMR 4 1994 603 614
68. Johnson B.A. Using NMRView to visualize and analyze the NMR spectra of macromolecules Methods Mol. Biol. 278 2004 313 352
69. Neidig K.P.; Geyer M.; Gorler A.; Antz C.; Saffrich R.; Beneicke W.; and Kalbitzer H. AURELIA, a program for computer-aided analysis of multidimensional NMR spectra J. Biomol. NMR 6 1995 255 270
70. Brunger A.T.; Adams P.D.; Clore G.M.; DeLano W.L.; Gros P.; and Grosse-Kunstleve R.W. Crystallography & NMR system: a new software suite for macromolecular structure determination Acta Crystallogr.; Sect. D: Biol. Crystallogr. 54 1998 905 921
71. Roberts G.C.K. NMR of macromolecules: A practical approach D. Rickwood, B.D. Hames, The Practical Approach Series 1993 Oxford University Press New York, NY
72. Gerstein M. A resolution-sensitive procedure for comparing protein surfaces and its application to the comparison of antigen-combining sites Acta Crystallogr.; Sect. A: Found. Crystallogr. 48 1992 271 276